Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis
Infectious Diseases and Therapy 14(8) (2025)
Qianqian Zhu; Chengde Su; Mingdan Li; Yali Xu; Qian Liu; Ying Zhang; Xinyi Zhang; Qiuxiang Li; Huajun Wang; Yawen Luo; Ping Yang
Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
Journal of Gastroenterology and Hepatology 40(9) (2025)
Tyng‐Yuan Jang; Chih‐Wen Wang; Po‐Cheng Liang; Yu‐Ju Wei; Ming‐Lun Yeh; Yi‐Hung Lin; Chao‐Kuan Huang; Pei‐Chien Tsai; Yu‐Min Ko; Yi‐Shan Tsai; Kuan‐Yu Chen; Ching‐Chih Lin; Zu‐Yau Lin; Jee‐Fu Huang; Chia‐Yen Dai; Chung‐Feng Huang; Wan‐Long Chuang; Ming‐Lung Yu
The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease
Hepatobiliary & Pancreatic Diseases International 24(5) (2025)
Mao-Ping Li; Kai-Zhong Luo
Unveiling low level viremia in chronic hepatitis B: challenges and new horizons
Frontiers in Cellular and Infection Microbiology 15 (2025)
Bingqing Wang; Tian Zeng; Wen Yin; Chengrui Ren; Yuting Chen; Liqin Qian; Peng Huang; Chuanlong Zhu; Ming Yue
Etiology-Based Treatment for Unresectable/Advanced Hepatocellular Carcinoma: Focus on Viral Hepatitis and Metabolic Dysfunction-Associated Steatohepatitis
Liver Cancer 15(3) (2025)
Frances Sze Kei Sun; Jeffrey Sum Lung Wong; Lung-Yi Mak; Carmen Chak-Lui Wong; Valerie Chew; Bryan Cho Wing Li; Roland Leung; Tan To Cheung; Thomas Yau
Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study
Virology Journal 22(1) (2025)
Guanghui Ren; Kaining Jia; Shi Yin; Yunpeng Guan; Qingwei Cong; Ying Zhu
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Clinical and Molecular Hepatology 31(Suppl) (2025)
Saisai Zhang; Lung-Yi Mak; Man-Fung Yuen; Wai-Kay Seto
Tissue-resident memory CD8+T cells might enhance HBV DNA clearance in CHB patients with MASLD complication and normal ALT via the CCL-CCR pathways
Frontiers in Cellular and Infection Microbiology 15 (2025)
Chao Cai; Wen-Xuan Shang; Si-Jie Zheng; Chen Chen; Ke Xu; Lu Chen; Ya-Jie Wang; Yu-Qun Wang; Rui-Cong Chen; Yi-Jing Cai; Hui-Fang Zhang; Chen Huang; Ji Lin; Bang-Guo Zhou; Xiu-Li Lin; Lei Zhang; Ming-Qin Lu
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Clinical and Molecular Hepatology 29(3) (2023)
Yu Jun Wong; Vy H. Nguyen; Hwai-I Yang; Jie Li; Michael Huan Le; Wan-Jung Wu; Nicole Xinrong Han; Khi Yung Fong; Elizebeth Chen; Connie Wong; Fajuan Rui; Xiaoming Xu; Qi Xue; Xin Yu Hu; Wei Qiang Leow; George Boon-Bee Goh; Ramsey Cheung; Grace Wong; Vincent Wai-Sun Wong; Ming-Whei Yu; Mindie H. Nguyen
Evaluation on Heterogeneity of Fatty Liver in Rats: A Multiparameter Quantitative Analysis by Dual Energy CT
Academic Radiology 26(5) (2019)
Qiuting Cao; Shufan Shang; Xinjun Han; Di Cao; Liqin Zhao
Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress
Molecular and Cellular Biochemistry 477(11) (2021)
Qichuang Liu; Maoyuan Mu; Huan Chen; Guoyuan Zhang; Yanqing Yang; Jun Chu; Ying Li; Fangwan Yang; Shide Lin
Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
BMJ Open Gastroenterology 7(1) (2020)
Ta-Wei Liu; Chung-Feng Huang; Ming-Lun Yeh; Pei-Chien Tsai; Tyng-Yuan Jang; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease
Journal of Viral Hepatitis 31(10) (2024)
Nishi H. Patel; Aaron Lucko; Alicia Vachon; Karen E. Doucette; Alnoor Ramji; Laura Sycuro; Trushar R. Patel; Kris Chadee; Maitreyi Raman; Guido van Marle; Carla Osiowy; Carla S. Coffin
Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis
PLOS ONE 11(5) (2016)
Marwa K. Ibrahim; Ghada Maher Salum; Noha G. Bader El Din; Reham M. Dawood; Ahmed Barakat; Ahmed Khairy; Mostafa K. El Awady
Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study
World Journal of Gastroenterology 22(47) (2016)
Dipanwita Das; Neelakshi Sarkar; Isha Sengupta; Ananya Pal; Debraj Saha; Manikankana Bandopadhyay; Chandrima Das; Jimmy Narayan; Shivram Prasad Singh; Runu Chakravarty
Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B
Alimentary Pharmacology & Therapeutics 54(9) (2021)
Qi Zheng; Biyao Zou; Yuankai Wu; Yeehui Yeo; Huizhen Wu; Christopher D Stave; Ramsey C. Cheung; Mindie H. Nguyen
Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study
Journal of Clinical Medicine 13(18) (2024)
Fadi Abu Baker; Abdel-Rauf Zeina; Randa Taher; Saif Abu Mouch; Ariel Israel
Chronic hepatitis B and non‐alcoholic fatty liver disease: Conspirators or competitors?
Liver International 40(3) (2020)
Jianbin Zhang; Shuangzhe Lin; Daixi Jiang; Mengting Li; Yuanwen Chen; Jun Li; Jiangao Fan
Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections
Expert Opinion on Drug Discovery 13(7) (2018)
Keye Du; Jia Liu; Ruth Broering; Xiaoyong Zhang; Dongliang Yang; Ulf Dittmer; Mengji Lu
Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
BMC Pulmonary Medicine 22(1) (2022)
Takahito Suzuki; Masato Karayama; Yusuke Inoue; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda
Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease
Chinese Medical Journal 135(14) (2022)
Xin Tong; Yu Song; Shengxia Yin; Jian Wang; Rui Huang; Chao Wu; Junping Shi; Jie Li
Sac1 phosphatidylinositol 4‐phosphate phosphatase is a novel host cell factor regulating hepatitis B virus particles assembly and release
The FEBS Journal 289(23) (2022)
Mirela‐Andreea Popescu; David Patriche; Mihaela‐Olivia Dobrica; Ana‐Maria Pantazica; Petruta‐Ramona Flintoaca (Alexandru); Yves Rouillé; Costin‐Ioan Popescu; Norica Branza‐Nichita
Intrinsic Immune Response of HBV/HDV-Infected Cells and Corresponding Innate (Like) Immune Cell Activation
Livers 4(4) (2024)
Christopher Groth; Svea Wupper; Gnimah Eva Gnouamozi; Katrin Böttcher; Adelheid Cerwenka
The link between TLR7 signaling and hepatitis B virus infection
Life Sciences 158 (2016)
Zahra Sepehri; Zohre Kiani; Seyed Moayed Alavian; Mohammad Kazemi Arababadi; Derek Kennedy
Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis
Canadian Liver Journal 4(3) (2021)
Micah Grubert Van Iderstine; J Uhanova; Gerald Y Minuk
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
Heliyon 9(1) (2023)
Lili Liu; Hong Li; Yang Zhang; Jing Zhang; Zhenhuan Cao
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
International Journal of Molecular Sciences 22(19) (2021)
Mohammad Enamul Hoque Kayesh; Michinori Kohara; Kyoko Tsukiyama-Kohara
Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink
Pathogens 13(1) (2024)
Cornelius J. Fernandez; Mohammed Alkhalifah; Hafsa Afsar; Joseph M. Pappachan
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Frontiers in Immunology 13 (2022)
Evanthia Tourkochristou; Stelios F. Assimakopoulos; Konstantinos Thomopoulos; Markos Marangos; Christos Triantos
Obesity management for the hepatologist—What to do, how to do it and why?
Hepatology 81(5) (2023)
Kymberly D. Watt; Sonali Paul; Mohammad Qasim Khan; Mohammad Siddiqui; Jenny Lam; Tayyab S. Diwan; Michael Camilleri
Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study
Liver Cancer (2024)
Chi-Ling Chen; Wei-Shiung Yang; Hwai-I. Yang; Chuen-Fei Chen; Li-Yu Wang; Sheng-Nan Lu; Jia-Horng Kao; Pei-Jer Chen; Chien-Jen Chen
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Nature Medicine 23(6) (2017)
Guang-Nian Zhao; Peng Zhang; Jun Gong; Xiao-Jing Zhang; Pi-Xiao Wang; Miao Yin; Zhou Jiang; Li-Jun Shen; Yan-Xiao Ji; Jingjing Tong; Yutao Wang; Qiao-Fang Wei; Yong Wang; Xue-Yong Zhu; Xin Zhang; Jing Fang; Qingguo Xie; Zhi-Gang She; Zhihua Wang; Zan Huang; Hongliang Li
Dietary Fatty Acids Amplify Inflammatory Responses to Infection through p38 MAPK Signaling
American Journal of Respiratory Cell and Molecular Biology 60(5) (2019)
Sandra Rutting; Razia Zakarya; Jack Bozier; Dia Xenaki; Jay C. Horvat; Lisa G. Wood; Philip M. Hansbro; Brian G. Oliver
Basic Research on Toll-Like Receptors in Metabolism-Related Fatty Liver Disease
Advances in Clinical Medicine 13(06) (2023)
晓阳 王
The Effects of Hepatic Steatosis on the Natural History of HBV Infection
Clinics in Liver Disease 23(3) (2019)
Idrees Suliman; Noha Abdelgelil; Farah Kassamali; Tarek I. Hassanein
Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water
Laboratory Investigation 98(9) (2018)
Xue-Jing Liu; Na-Na Duan; Chang Liu; Chen Niu; Xiu-Ping Liu; Jian Wu
Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection
Scientific Reports 9(1) (2019)
Xianzhong Jiang; Bin Zhang; Junsheng Zhao; Yi Xu; Haijun Han; Kunkai Su; Jingjing Tao; Rongli Fan; Xinyi Zhao; Lanjuan Li; Ming D. Li
The Association Between Weight Loss and Hepatitis B Surface Antigen Seroclearence in Chronic Hepatitis B Patients
Hepatitis Monthly 24(1) (2024)
Nazan Tuna; Aylin Çalıca Utku; Aslı Vatan; Aziz Ogutlu; Ertugrul Guclu; Oğuz Karabay
Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
World Journal of Hepatology 14(4) (2022)
Yu-Ge Zhou; Ning Tian; Wei-Ning Xie
Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study
Virology Journal 21(1) (2024)
Sitong Yi; Guanghui Ren; Ying Zhu; Qingwei Cong
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
The Journal of Infectious Diseases 224(11) (2021)
Yao-Chun Hsu; Ming-Lun Yeh; Grace Lai-Hung Wong; Chien-Hung Chen; Cheng-Yuan Peng; Maria Buti; Masaru Enomoto; Qing Xie; Huy Trinh; Carmen Preda; Li Liu; Ka-Shing Cheung; Yee Hui Yeo; Joseph Hoang; Chung-Feng Huang; Mar Riveiro-Barciela; Ritsuzo Kozuka; Doina Istratescu; Pei-Chien Tsai; Elena Vargas Accarino; Dong-Hyun Lee; Jia-Ling Wu; Jee Fu Huang; Chia-Yen Dai; Ramsey Cheung; Wan-Long Chuang; Man-Fung Yuen; Vincent Wai-Sun Wong; Ming-Lung Yu; Mindie H Nguyen
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
The Journal of Infectious Diseases 224(2) (2020)
Jie Li; Hwai-I Yang; Ming-Lun Yeh; Michael H Le; An K Le; Yee Hui Yeo; Chia-Yen Dai; Scott Barnett; Jian Q Zhang; Jee-Fu Huang; Huy N Trinh; Christopher Wong; Clifford Wong; Joseph K Hoang; Ramsey Cheung; Ming-Lung Yu; Mindie H Nguyen